BSE Live
Feb 03, 16:01Prev. Close
1420.15
Open Price
1423.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 03, 15:47Prev. Close
1417.70
Open Price
1443.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1405.80 (207)
| Balance Sheet of Dr Lal PathLabs (in Rs. Cr.) | Mar 15 | |
| 12 mths | ||
| EQUITIES AND LIABILITIES | ||
| SHAREHOLDER'S FUNDS | ||
| Equity Share Capital | 54.63 | |
| Total Share Capital | 81.26 | |
| Reserves and Surplus | 259.82 | |
| Total Reserves and Surplus | 259.82 | |
| Total Shareholders Funds | 314.45 | |
| Minority Interest | 2.30 | |
| NON-CURRENT LIABILITIES | ||
| Long Term Borrowings | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | |
| Other Long Term Liabilities | 19.97 | |
| Long Term Provisions | 0.21 | |
| Total Non-Current Liabilities | 46.81 | |
| CURRENT LIABILITIES | ||
| Short Term Borrowings | 0.00 | |
| Trade Payables | 34.16 | |
| Other Current Liabilities | 58.59 | |
| Short Term Provisions | 19.02 | |
| Total Current Liabilities | 111.76 | |
| Total Capital And Liabilities | 475.31 | |
| ASSETS | ||
| NON-CURRENT ASSETS | ||
| Tangible Assets | 90.56 | |
| Intangible Assets | 17.95 | |
| Capital Work-In-Progress | 0.95 | |
| Fixed Assets | 109.45 | |
| Non-Current Investments | 0.00 | |
| Deferred Tax Assets [Net] | 25.40 | |
| Long Term Loans And Advances | 13.94 | |
| Other Non-Current Assets | 3.27 | |
| Total Non-Current Assets | 193.64 | |
| CURRENT ASSETS | ||
| Current Investments | 37.92 | |
| Inventories | 14.28 | |
| Trade Receivables | 30.96 | |
| Cash And Cash Equivalents | 148.19 | |
| Short Term Loans And Advances | 45.71 | |
| OtherCurrentAssets | 4.62 | |
| Total Current Assets | 281.67 | |
| Total Assets | 475.31 | |
| OTHER ADDITIONAL INFORMATION | ||
| CONTINGENT LIABILITIES, COMMITMENTS | ||
| Contingent Liabilities | 11.56 | |
| BONUS DETAILS | ||
| Bonus Equity Share Capital | 50.32 | |
| NON-CURRENT INVESTMENTS | ||
| Non-Current Investments Quoted Market Value | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.00 | |
| CURRENT INVESTMENTS | ||
| Current Investments Quoted Market Value | 38.08 | |
| Current Investments Unquoted Book Value | 37.92 |
03.02.2026
Dr Lal PathLab Standalone December 2025 Net Sales at Rs 632.10 crore, up 19.69% Y-o-Y
05.12.2025
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
03.02.2026
Dr Lal PathLab Standalone December 2025 Net Sales at Rs 632.10 crore, up 19.69% Y-o-Y
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak